• 30860 Citations
  • 94 Scopus h-Index
19962020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1996 2019

2013
2 Citations (Scopus)

Non-secretory myeloma: clinical and biologic implications.

Fonseca, R., Sep 2013, In : Oncology (Williston Park, N.Y.). 27, 9, p. 932-933 2 p.

Research output: Contribution to journalArticle

Multiple Myeloma
131 Citations (Scopus)

Plasma cell leukemia: Consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

Fernández De Larrea, C., Kyle, R. A., Durie, B. G. M., Ludwig, H., Usmani, S., Vesole, D. H., Hajek, R., San Miguel, J. F., Sezer, O., Sonneveld, P., Kumar, S. K., Mahindra, A., Comenzo, R., Palumbo, A., Mazumber, A., Anderson, K. C., Richardson, P. G., Badros, A. Z., Caers, J., Cavo, M. & 16 others, Leleu, X., Dimopoulos, M. A., Chim, C. S., Schots, R., Noeul, A., Fantl, D., Mellqvist, U. H., Landgren, O., Chanan Khan, A. A., Moreau, P., Fonseca, R., Merlini, G., Lahuerta, J. J., Bladé, J., Orlowski, R. Z. & Shah, J. J., Apr 2013, In : Leukemia. 27, 4, p. 780-791 12 p.

Research output: Contribution to journalArticle

Plasma Cell Leukemia
Plasma Cells
Therapeutics
Homologous Transplantation
Stem Cell Transplantation
1 Citation (Scopus)

Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalities

Jimenez-Zepeda, V. H., Chng, W. J., Schop, R. F. J., Braggio, E. D., Leis, J. F., Kay, N. E. & Fonseca, R., Aug 2013, In : Clinical Lymphoma, Myeloma and Leukemia. 13, 4, p. 467-476 10 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Chromosome Aberrations
Neoplasms
Chromosomes, Human, 13-15
Cyclin D2
54 Citations (Scopus)

Smoldering multiple myeloma requiring treatment: Time for a new definition?

Dispenzieri, A., Stewart, A. K., Chanan Khan, A. A., Rajkumar, S. V., Kyle, R. A., Fonseca, R., Kapoor, P., Bergsagel, P. L., McCurdy, A., Gertz, M., Lacy, M., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Reeder, C., Roy, V., Buadi, F., Dingli, D. M., Hayman, S. R., Leung, N. & 3 others, Lin, Y., Mikhael, J. R. & Kumar, S. K., Dec 19 2013, In : Blood. 122, 26, p. 4172-4181 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Bone
Air cushion vehicles
Dexamethasone
Immunoglobulins
5 Citations (Scopus)

The MYDas touch of next-gen sequencing.

Fonseca, R. & Braggio, E. D., Mar 28 2013, In : Blood. 121, 13, p. 2373-2374 2 p.

Research output: Contribution to journalArticle

Myeloid Differentiation Factor 88
Waldenstrom Macroglobulinemia
Touch
Missense Mutation
Lymphoma
25 Citations (Scopus)

Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach.

Baker, A., Braggio, E. D., Jacobus, S., Jung, S., Larson, D., Therneau, T. M., Dispenzieri, A., Van Wier, S. A., Ahmann, G., Levy, J., Perkins, L., Kim, S., Henderson, K., Vesole, D., Rajkumar, S. V., Jelinek, D. F., Carpten, J. & Fonseca, R., Apr 18 2013, In : Blood. 121, 16, p. 3147-3152 6 p.

Research output: Contribution to journalArticle

Oncology
Genomics
Multiple Myeloma
African Americans
Tumors

Waldenström macroglobulinemia

Fonseca, R., Hayman, S. R. & Ansell, S. M., Oct 17 2013, Wintrobe's Clinical Hematology: Thirteenth Edition. Wolters Kluwer Health Adis (ESP), p. 2124-2140 17 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Waldenstrom Macroglobulinemia
2012
13 Citations (Scopus)

Absence of tissue factor expression by neoplastic plasma cells in multiple myeloma

Cesarman-Maus, G., Braggio, E. D., Maldonado, H. & Fonseca, R., Jul 2012, In : Leukemia. 26, 7, p. 1671-1674 4 p.

Research output: Contribution to journalArticle

Thromboplastin
Plasma Cells
Multiple Myeloma
Neoplasms
Thrombosis
43 Citations (Scopus)

A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma

Khan, M. L., Reeder, C. B., Kumar, S. K., Lacy, M., Reece, D. E., Dispenzieri, A., Gertz, M., Greipp, P., Hayman, S., Zeldenhurst, S., Dingli, D. M., Lust, J., Russell, S. J., Laumann, K. M., Mikhael, J. R., Bergsagel, P. L., Fonseca, R., Rajkumar, S. V. & Stewart, A. K., Feb 2012, In : British Journal of Haematology. 156, 3, p. 326-333 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Cyclophosphamide
Dexamethasone
Disease-Free Survival
Therapeutics
84 Citations (Scopus)

Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis

Dispenzieri, A., Buadi, F., Laumann, K., LaPlant, B., Hayman, S. R., Kumar, S. K., Dingli, D. M., Zeldenrust, S. R., Mikhael, J. R., Hall, R., Rajkumar, S. V., Reeder, C., Fonseca, R., Bergsagel, P. L., Stewart, A. K., Roy, V., Witzig, T. E., Lust, J. A., Russell, S. J., Gertz, M. & 1 others, Lacy, M., Jun 7 2012, In : Blood. 119, 23, p. 5397-5404 8 p.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
Amyloidosis
Natriuretic Peptides
Pharmaceutical Preparations
Dexamethasone
31 Citations (Scopus)

An Integrated Genomic and Expression Analysis of 7q Deletion in Splenic Marginal Zone Lymphoma

Watkins, A. J., Hamoudi, R. A., Zeng, N., Yan, Q., Huang, Y., Liu, H., Zhang, J., Braggio, E. D., Fonseca, R., de Leval, L., Isaacson, P. G., Wotherspoon, A., McPhail, E., Dogan, A. & Du, M. Q., Sep 13 2012, In : PLoS One. 7, 9, e44997.

Research output: Contribution to journalArticle

lymphoma
Lymphoma
Genes
MicroRNAs
genomics
6 Citations (Scopus)
Translational Medical Research
African Americans
Research
Neoplasms
Multiple Myeloma
3 Citations (Scopus)

Association of clinical researchers and educators a statement on relationships between physicians and industry

Weber, M. A., Black, H. R., Fonseca, R., Garber, J., Gonzalez-Campoy, J. M., Kimmelstiel, C., Markowitz, A. B., Nakayama, D., Stell, L. K. & Stossel, T. P., Nov 1 2012, In : Endocrine Practice. 18, 6, p. 1029-1037 9 p.

Research output: Contribution to journalArticle

Industry
Research Personnel
Physicians
Professional Practice
Routine Diagnostic Tests
386 Citations (Scopus)

Clonal competition with alternating dominance in multiple myeloma

Keats, J. J., Chesi, M., Egan, J. B., Garbitt, V. M., Palmer, S. E., Braggio, E. D., Van Wier, S., Blackburn, P. R., Baker, A. S., Dispenzieri, A., Kumar, S. K., Rajkumar, S. V., Carpten, J. D., Barrett, M., Fonseca, R., Stewart, A. K. & Bergsagel, P. L., Aug 2 2012, In : Blood. 120, 5, p. 1067-1076 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Tumors
Clone Cells
Genes
Neoplasms
23 Citations (Scopus)

Content development for the functional assessment of cancer therapy-multiple myeloma (FACT-MM): Use of qualitative and quantitative methods for scale construction

Wagner, L. I., Robinson, D., Weiss, M., Katz, M., Greipp, P., Fonseca, R. & Cella, D., Jun 2012, In : Journal of Pain and Symptom Management. 43, 6, p. 1094-1104 11 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Quality of Life
Neoplasms
Therapeutics
Pain
201 Citations (Scopus)

Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis

Mikhael, J. R., Schuster, S. R., Jimenez-Zepeda, V. H., Bello, N., Spong, J., Reeder, C. B., Stewart, A. K., Bergsagel, P. L. & Fonseca, R., May 10 2012, In : Blood. 119, 19, p. 4391-4394 4 p.

Research output: Contribution to journalArticle

Amyloidosis
Cyclophosphamide
Dexamethasone
Stem Cell Transplantation
Stem cells
17 Citations (Scopus)

DNA Methylation in Multiple Myeloma Is Weakly Associated with Gene Transcription

Jung, S., Kim, S., Gale, M., Cherni, I., Fonseca, R., Carpten, J. & Salhia, B., Dec 20 2012, In : PLoS One. 7, 12, e52626.

Research output: Contribution to journalArticle

myeloma
Methylation
DNA methylation
DNA Methylation
Transcription
1 Citation (Scopus)

Frontline treatment of multiple myeloma

Fonseca, R., Apr 2012, In : Hematology. 17, SUPPL. 1

Research output: Contribution to journalArticle

Multiple Myeloma
Therapeutics
Stem Cells
Clinical Trials
Transplants
119 Citations (Scopus)

Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas

Vasmatzis, G., Johnson, S. H., Knudson, R. A., Ketterling, R. P., Braggio, E. D., Fonseca, R., Viswanatha, D. S., Law, M. E., Kip, N. S., Özsan, N., Grebe, S. K., Frederick, L. A., Eckloff, B. W., Thompson, E. A., Kadin, M. E., Milosevic, D., Porcher, J. C., Asmann, Y., Smith, D. I., Kovtun, I. V. & 3 others, Ansell, S. M., Dogan, A. & Feldman, A. L., Sep 13 2012, In : Blood. 120, 11, p. 2280-2289 10 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
T-cells
p53 Genes
Genes
Genome
53 Citations (Scopus)

Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing

Liang, W. S., Craig, D. W., Carpten, J., Borad, M. J., Demeure, M. J., Weiss, G. J., Izatt, T., Sinari, S., Christoforides, A., Aldrich, J., Kurdoglu, A., Barrett, M., Phillips, L., Benson, H., Tembe, W., Braggio, E. D., Kiefer, J. A., Legendre, C., Posner, R., Hostetter, G. H. & 9 others, Baker, A., Egan, J. B., Han, H., Lake, D., Stites, E. C., Ramanathan, R. K., Fonseca, R., Stewart, A. K. & von Hoff, D., Oct 10 2012, In : PLoS One. 7, 10, e43192.

Research output: Contribution to journalArticle

adenocarcinoma
Tumors
Adenocarcinoma
Genes
Genome
44 Citations (Scopus)

Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities

Braggio, E. D., Dogan, A., Keats, J. J., Chng, W. J., Huang, G., Matthews, J. M., Maurer, M. J., Law, M. E., Bosler, D. S., Barrett, M., Lossos, I. S., Witzig, T. E. & Fonseca, R., May 2012, In : Modern Pathology. 25, 5, p. 651-660 10 p.

Research output: Contribution to journalArticle

Lymphoma
Marginal Zone B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Chromosomes, Human, Pair 18
Chromosomes, Human, Pair 12

How physicians interpret research funding disclosures [3]

Fonseca, R., Dec 13 2012, In : New England Journal of Medicine. 367, 24, p. 2358-2360 3 p.

Research output: Contribution to journalLetter

Drug Evaluation
Disclosure
Research Design
Physicians
Research
82 Citations (Scopus)

Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: Long-term results from a phase 2 trial

Kumar, S. K., Hayman, S. R., Buadi, F. K., Roy, V., Lacy, M., Gertz, M., Allred, J., Laumann, K. M., Bergsagel, P. L., Dingli, D. M., Mikhael, J. R., Reeder, C. B., Stewart, A. K., Zeldenrust, S. R., Greipp, P. R., Lust, J. A., Fonseca, R., Russell, S. J., Rajkumar, S. V. & Dispenzieri, A., May 24 2012, In : Blood. 119, 21, p. 4860-4867 8 p.

Research output: Contribution to journalArticle

Amyloidosis
Cyclophosphamide
Dexamethasone
Toxicity
Light
34 Citations (Scopus)

Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse

Braggio, E. D., Kay, N. E., Vanwier, S., Tschumper, R. C., Smoley, S., Eckel-Passow, J. E., Sassoon, T., Barrett, M., Van Dyke, D. L., Byrd, J. C., Jelinek, D. F., Shanafelt, T. D. & Fonseca, R., Jul 2012, In : Leukemia. 26, 7, p. 1698-1701 4 p.

Research output: Contribution to journalArticle

Clonal Evolution
Molecular Evolution
Human Genome
B-Cell Chronic Lymphocytic Leukemia
Chromosome Aberrations
18 Citations (Scopus)

Molecular pathogenesis of Waldenström's macroglobulinemia

Braggio, E. D., Philipsborn, C., Novak, A. J., Hodge, L., Ansell, S. M. & Fonseca, R., Sep 1 2012, In : Haematologica. 97, 9, p. 1281-1290 10 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Immunoglobulin M
Biomarkers
Bone Marrow
Research
25 Citations (Scopus)

t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth

Ansell, S. M., Akasaka, T., McPhail, E., Manske, M., Braggio, E. D., Price-Troska, T., Ziesmer, S., Secreto, F., Fonseca, R., Gupta, M., Law, M., Witzig, T. E., Dyer, M. J. S., Dogan, A., Cerhan, J. R. & Novak, A. J., Nov 8 2012, In : Blood. 120, 19, p. 3949-3957 9 p.

Research output: Contribution to journalArticle

Marginal Zone B-Cell Lymphoma
Cell growth
Tumors
Lymphoma
Growth
26 Citations (Scopus)

Thrombosis in multiple myeloma (MM)

Cesarman-Maus, G., Braggio, E. D. & Fonseca, R., Apr 2012, In : Hematology. 17, SUPPL. 1

Research output: Contribution to journalArticle

Multiple Myeloma
Thrombosis
cancer procoagulant
Thalidomide
Anthracyclines
141 Citations (Scopus)

Trisomies in multiple myeloma: Impact on survival in patients with high-risk cytogenetics

Kumar, S. K., Fonseca, R., Ketterling, R. P., Dispenzieri, A., Lacy, M., Gertz, M., Hayman, S. R., Buadi, F. K., Dingli, D. M., Knudson, R. A., Greenberg, A., Russell, S. J., Zeldenrust, S. R., Lust, J. A., Kyle, R. A., Bergsagel, P. L. & Rajkumar, S. V., Mar 1 2012, In : Blood. 119, 9, p. 2100-2105 6 p.

Research output: Contribution to journalArticle

Trisomy
Multiple Myeloma
Cytogenetics
Chromosomes
Survival
264 Citations (Scopus)

Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides

Egan, J. B., Shi, C. X., Tembe, W., Christoforides, A., Kurdoglu, A., Sinari, S., Middha, S., Asmann, Y., Schmidt, J., Braggio, E. D., Keats, J. J., Fonseca, R., Bergsagel, P. L., Craig, D. W., Carpten, J. D. & Stewart, A. K., Aug 2 2012, In : Blood. 120, 5, p. 1060-1066 7 p.

Research output: Contribution to journalArticle

Plasma Cell Leukemia
Clonal Evolution
Tides
Multiple Myeloma
Tumors
2011
348 Citations (Scopus)

Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide

Zhu, Y. X., Braggio, E. D., Shi, C. X., Bruins, L. A., Schmidt, J. E., Van Wier, S., Chang, X-B. D., Bjorklund, C. C., Fonseca, R., Bergsagel, P. L., Orlowski, R. Z. & Stewart, A. K., Nov 3 2011, In : Blood. 118, 18, p. 4771-4779 9 p.

Research output: Contribution to journalArticle

Thalidomide
Melphalan
Biomarkers
Gene expression
Pharmaceutical Preparations
150 Citations (Scopus)

Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma

Chng, W. J., Huang, G. F., Chung, T. H., Ng, S. B., Gonzalez-Paz, N., Troska-Price, T., Mulligan, G., Chesi, M., Bergsagel, P. L. & Fonseca, R., Jun 2011, In : Leukemia. 25, 6, p. 1026-1035 10 p.

Research output: Contribution to journalArticle

Monoclonal Gammopathy of Undetermined Significance
Multiple Myeloma
Immunohistochemistry
cdc Genes
Polyploidy
238 Citations (Scopus)

Consensus recommendations for risk stratification in multiple myeloma: Report of the International Myeloma Workshop Consensus Panel 2

Munshi, N. C., Anderson, K. C., Bergsagel, P. L., Shaughnessy, J., Palumbo, A., Durie, B., Fonseca, R., Stewart, A. K., Harousseau, J. L., Dimopoulos, M., Jagannath, S., Hajek, R., Sezer, O., Kyle, R., Sonneveld, P., Cavo, M., Rajkumar, S. V., San Miguel, J., Crowley, J. & Avet-Loiseau, H., May 5 2011, In : Blood. 117, 18, p. 4696-4700 5 p.

Research output: Contribution to journalArticle

Consensus Development Conferences
Multiple Myeloma
Fluorescence In Situ Hybridization
Fluorescence
Recurrence
29 Citations (Scopus)

Establishment and characterization of a novel Waldenström macroglobulinemia cell line, MWCL-1

Hodge, L. S., Novak, A. J., Grote, D. M., Braggio, E. D., Ketterling, R. P., Manske, M. K., Price Troska, T. L., Ziesmer, S. C., Fonseca, R., Witzig, T. E., Morice, W. G., Gertz, M. & Ansell, S. M., May 12 2011, In : Blood. 117, 19

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Tumors
Cells
Cell Line
Tumor Cell Line
14 Citations (Scopus)

High-throughput genomic analysis in Waldenström's macroglobulinemia

Poulain, S., Braggio, E. D., Roumier, C., Aijjou, R., Broucqsault, N., Galiègue-Zouitina, S., Manier, S., Soenen, V., Nibourel, O., Duthilleul, P., Fonseca, R. & Leleu, X., Feb 1 2011, In : Clinical Lymphoma, Myeloma and Leukemia. 11, 1, p. 106-108 3 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Comparative Genomic Hybridization
Single Nucleotide Polymorphism
TNF Receptor-Associated Factor 3
Uniparental Disomy
26 Citations (Scopus)

Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone

Kumar, S. K., Uno, H., Jacobus, S. J., Van Wier, S. A., Ahmann, G. J., Henderson, K. J., Callander, N. S., Haug, J. L., Siegel, D. S., Greipp, P. R., Fonseca, R. & Rajkumar, S. V., Oct 20 2011, In : Blood. 118, 16, p. 4359-4362 4 p.

Research output: Contribution to journalArticle

Gene Expression Profiling
Gene expression
Dexamethasone
Therapeutics
lenalidomide
24 Citations (Scopus)

Impact of high-risk classification by FISH: An Eastern Cooperative Oncology Group (ECOG) study E4A03

Jacobus, S. J., Kumar, S. K., Uno, H., van Wier, S. A., Ahmann, G. J., Henderson, K. J., Callander, N. S., Williams, M. E., Siegel, D. S., Greipp, P. R., Rajkumar, S. V. & Fonseca, R., Nov 2011, In : British Journal of Haematology. 155, 3, p. 340-348 9 p.

Research output: Contribution to journalArticle

Fluorescence In Situ Hybridization
Multiple Myeloma
Dexamethasone
Survival
Phase III Clinical Trials
920 Citations (Scopus)

Initial genome sequencing and analysis of multiple myeloma

Chapman, M. A., Lawrence, M. S., Keats, J. J., Cibulskis, K., Sougnez, C., Schinzel, A. C., Harview, C. L., Brunet, J. P., Ahmann, G. J., Adli, M., Anderson, K. C., Ardlie, K. G., Auclair, D., Baker, A., Bergsagel, P. L., Bernstein, B. E., Drier, Y., Fonseca, R., Gabriel, S. B., Hofmeister, C. C. & 30 others, Jagannath, S., Jakubowiak, A. J., Krishnan, A., Levy, J., Liefeld, T., Lonial, S., Mahan, S., Mfuko, B., Monti, S., Perkins, L. M., Onofrio, R., Pugh, T. J., Rajkumar, S. V., Ramos, A. H., Siegel, D. S., Sivachenko, A., Stewart, A. K., Trudel, S., Vij, R., Voet, D., Winckler, W., Zimmerman, T., Carpten, J., Trent, J., Hahn, W. C., Garraway, L. A., Meyerson, M., Lander, E. S., Getz, G. & Golub, T. R., Mar 24 2011, In : Nature. 471, 7339, p. 467-472 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Genome
Mutation
Neoplasms
Proto-Oncogene Proteins B-raf
2 Citations (Scopus)

Innovation in myeloma treatments PARP excellence!

Fonseca, R., Dec 8 2011, In : Blood. 118, 24, p. 6234-6235 2 p.

Research output: Contribution to journalArticle

Blood
Innovation
Enzymes
Bortezomib
43 Citations (Scopus)

Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial

Kumar, S. K., Lacy, M., Hayman, S. R., Stewart, A. K., Buadi, F. K., Allred, J., Laumann, K., Greipp, P. R., Lust, J. A., Gertz, M., Zeldenrust, S. R., Bergsagel, P. L., Reeder, C. B., Witzig, T. E., Fonseca, R., Russell, S. J., Mikhael, J. R., Dingli, D. M., Rajkumar, S. V. & Dispenzieri, A., Aug 2011, In : American Journal of Hematology. 86, 8, p. 640-645 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Cyclophosphamide
Dexamethasone
Disease-Free Survival
Survival
13 Citations (Scopus)

MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts

Hodge, L. S., Elsawa, S. F., Grote, D. M., Price-Troska, T. L., Asmann, Y., Fonseca, R., Gertz, M., Witzig, T. E., Novak, A. J. & Ansell, S. M., Jun 2011, In : Blood Cancer Journal. 1, 6, e24.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
MicroRNAs
Neoplasms
B-Lymphocytes
Hematopoiesis
26 Citations (Scopus)

Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants

Jimenez-Zepeda, V. H., Heilman, R. L., Engel, R. A., Carey, E. J., Freeman, C., Rakela, J., Mulligan, D. C., Fonseca, R. & Stewart, A. K., Sep 15 2011, In : Transplantation. 92, 5, p. 570-574 5 p.

Research output: Contribution to journalArticle

Monoclonal Gammopathy of Undetermined Significance
Transplants
Lymphoproliferative Disorders
Multiple Myeloma
Paraproteinemias
56 Citations (Scopus)

Plasma cell leukemia

Albarracin, F. & Fonseca, R., May 2011, In : Blood Reviews. 25, 3, p. 107-112 6 p.

Research output: Contribution to journalArticle

Plasma Cell Leukemia
Multiple Myeloma
Plasma Cells
Electrophoresis
Plasma Cell Neoplasms
173 Citations (Scopus)

Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: Comparison of 2 dosing strategies in dual-refractory disease

Lacy, M., Allred, J. B., Gertz, M., Hayman, S. R., Short, K. D., Buadi, F., Dispenzieri, A., Kumar, S. K., Greipp, P. R., Lust, J. A., Russell, S. J., Dingli, D. M., Zeldenrust, S., Fonseca, R., Bergsagel, P. L., Roy, V., Stewart, A. K., Laumann, K., Mandrekar, S. J., Reeder, C. & 2 others, Rajkumar, S. V. & Mikhael, J. R., Sep 15 2011, In : Blood. 118, 11, p. 2970-2975 6 p.

Research output: Contribution to journalArticle

Refractory materials
Dexamethasone
Multiple Myeloma
Toxicity
Survival
35 Citations (Scopus)

Primary central nervous system lymphomas: A validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens

Braggio, E. D., McPhail, E., Macon, W., Lopes, M. B., Schiff, D., Law, M., Fink, S., Sprau, D., Giannini, C., Dogan, A., Fonseca, R. & O'Neill, B. P., Jul 1 2011, In : Clinical Cancer Research. 17, 13, p. 4245-4253 9 p.

Research output: Contribution to journalArticle

Comparative Genomic Hybridization
Validation Studies
Paraffin
Formaldehyde
Lymphoma
1 Citation (Scopus)
High-Throughput Nucleotide Sequencing
Precision Medicine
Translational Medical Research
Human Genome
Multiple Myeloma
2010
41 Citations (Scopus)

Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma

Gay, F., Rajkumar, S. V., Coleman, M., Kumar, S. K., Mark, T., Dispenzieri, A., Pearse, R., Gertz, M., Leonard, J., Lacy, M., Chen-Kiang, S., Roy, V., Jayabalan, D. S., Lust, J. A., Witzig, T. E., Fonseca, R., Kyle, R. A., Greipp, P. R., Stewart, A. K. & Niesvizky, R., 2010, In : American Journal of Hematology. 85, 9, p. 664-669 6 p.

Research output: Contribution to journalArticle

Clarithromycin
Dexamethasone
Birds
Intention to Treat Analysis
Thrombocytopenia
1 Citation (Scopus)

Conflicts of interest, authorship, and disclosures in industry-related scientific publications

Fonseca, R., Richardson, P., Giralt, S., Lonial, S., Rajkumar, S. V., Stewart, A. K., Bensinger, W., Somlo, G., Vescio, R., Mikhael, J. R., Reeder, C., Tiedemann, R., Tricot, G., Rifkin, R., Shaughnessy, J., Munshi, N., Raje, N., Ghobrial, I., Laubach, J., Schlossman, R. & 47 others, Treon, S., Mahindra, A., Avigan, D., Rosenblatt, J., Jagannath, S., Niesvizky, R., Landau, H., Chen-Kiang, S., Siegel, D. S., Zimmerman, T., Mehta, J., Vesole, D., Rosen, S., Hofmeister, C., Lacy, M., Dispenzieri, A., Borrello, I., Hayman, S. R., Kumar, S. K., Buadi, F., Dingli, D. M., Russell, S. J., Alsina, M., Fernandez, H., Roy, V., Pereira, D., Stadtmauer, E., Vij, R., Jakubowiak, A., Lentzsch, S., Song, K., Bahlis, N., Trudel, S., Chen, C., Reece, D., Stewart, D., Singhal, S., Comenzo, R., Gertz, M., Greipp, P. R., Durie, B., Barlogie, B., Anderson, K., Dalton, W., Coleman, M., Novis, S. & Kyle, R. A., 2010, In : Mayo Clinic Proceedings. 85, 2, p. 197-199 3 p.

Research output: Contribution to journalArticle

Continuing medical education - Limiting industry's influence [7]

Fonseca, R., Mar 18 2010, In : New England Journal of Medicine. 362, 11, p. 1053 1 p.

Research output: Contribution to journalArticle

Financial Support
Conflict of Interest
Continuing Medical Education
Industry
35 Citations (Scopus)

Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: Identification of 1p31-32 deletion as a prognostic factor in myeloma

Chng, W. J., Gertz, M., Chung, T. H., Van Wier, S., Keats, J. J., Baker, A., Bergsagel, P. L., Carpten, J. & Fonseca, R., Apr 2010, In : Leukemia. 24, 4, p. 833-842 10 p.

Research output: Contribution to journalArticle

Comparative Genomic Hybridization
Survival
Melphalan
Stem Cell Transplantation
Fluorescence In Situ Hybridization
103 Citations (Scopus)

Diagnosis and management of waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

Ansell, S. M., Kyle, R. A., Reeder, C. B., Fonseca, R., Mikhael, J. R., Morice, W. G., Bergsagel, P. L., Buadi, F. K., Colgan, J. P., Dingli, D. M., Dispenzieri, A., Greipp, P. R., Habermann, T. M., Hayman, S. R., Inwards, D. J., Johnston, P. B., Kumar, S. K., Lacy, M., Lust, J. A., Markovic, S. N. & 13 others, Micallef, I., Nowakowski, G. S., Porrata, L. F., Roy, V., Russell, S. J., Detweiler Short, K. E., Stewart, A. K., Thompson, C. A., Witzig, T. E., Zeldenrust, S. R., Dalton, R. J., Rajkumar, S. V. & Gertz, M., 2010, In : Mayo Clinic Proceedings. 85, 9, p. 824-833 10 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Guidelines
Therapeutics
Immunoglobulin M
Plasmapheresis